New antiarrhythmic drugs for treatment of atrial fibrillation

D Dobrev, S Nattel - The Lancet, 2010 - thelancet.com
Inadequacies in current therapies for atrial fibrillation have made new drug development
crucial. Conventional antiarrhythmic drugs increase the risk of ventricular proarrhythmia. In …
被引用次数：371 相关文章

New antiarrhythmic drugs for treatment of atrial fibrillation

D Dobrev, S Nattel - The Lancet, 2010 - thelancet.com
Inadequacies in current therapies for atrial fibrillation have made new drug development
crucial. Conventional antiarrhythmic drugs increase the risk of ventricular proarrhythmia. In …

New antiarrhythmic drugs for treatment of atrial fibrillation

D Dobrev, S Nattel - The Lancet, 2010 - infona.pl
Inadequacies in current therapies for atrial fibrillation have made new drug development
crucial. Conventional antiarrhythmic drugs increase the risk of ventricular proarrhythmia. In …

[引用][C] New antiarrhythmic drugs for treatment of atrial fibrillation

D DOBREV, S NATTEL - Lancet (British edition), 2010 - pascal-francis.inist.fr
New antiarrhythmic drugs for treatment of atrial fibrillation CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

New antiarrhythmic drugs for treatment of atrial fibrillation.

D Dobrev, S Nattel - Lancet (London, England), 2010 - europepmc.org
Inadequacies in current therapies for atrial fibrillation have made new drug development
crucial. Conventional antiarrhythmic drugs increase the risk of ventricular proarrhythmia. In …

[引用][C] New antiarrhythmic drugs for treatment of atrial fibrillation

D Dobrev, S Nattel - The Lancet, 2010 - cir.nii.ac.jp
New antiarrhythmic drugs for treatment of atrial fibrillation | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

New antiarrhythmic drugs for treatment of atrial fibrillation

D Dobrev, S Nattel - The Lancet, 2010 - Elsevier
Inadequacies in current therapies for atrial fibrillation have made new drug development
crucial. Conventional antiarrhythmic drugs increase the risk of ventricular proarrhythmia. In …

New antiarrhythmic drugs for treatment of atrial fibrillation

D Dobrev, S Nattel - Lancet (London, England), 2010 - pubmed.ncbi.nlm.nih.gov
Inadequacies in current therapies for atrial fibrillation have made new drug development
crucial. Conventional antiarrhythmic drugs increase the risk of ventricular proarrhythmia. In …

[引用][C] New antiarrhythmic drugs for treatment of atrial fibrillation

D Dobrev, S Nattel - The Lancet, 2010 - Elsevier Limited

[引用][C] New antiarrhythmic drugs for treatment of atrial fibrillation

D DOBREV, S NATTEL - Lancet, 2010 - Elsevier